OP0050 ADDITIVE VALUE AND DIAGNOSTIC ACCURACY OF DUAL-ENERGY CT FOR THE DIAGNOSIS OF GOUT: A PROSPECTIVE STUDY IN SUBJECTS WITH UNCLASSIFIED MONO OR OLIGOARTHRITIS. (June 2019)
- Record Type:
- Journal Article
- Title:
- OP0050 ADDITIVE VALUE AND DIAGNOSTIC ACCURACY OF DUAL-ENERGY CT FOR THE DIAGNOSIS OF GOUT: A PROSPECTIVE STUDY IN SUBJECTS WITH UNCLASSIFIED MONO OR OLIGOARTHRITIS. (June 2019)
- Main Title:
- OP0050 ADDITIVE VALUE AND DIAGNOSTIC ACCURACY OF DUAL-ENERGY CT FOR THE DIAGNOSIS OF GOUT: A PROSPECTIVE STUDY IN SUBJECTS WITH UNCLASSIFIED MONO OR OLIGOARTHRITIS
- Authors:
- Gamala, Mihaela
Jacobs, Johannes W. G.
Linn-Rasker, Suzanne
Nix, Maarten
Heggelman, Ben
Pasker, Pieternel
van Laar, Jacob M.
Klaasen, Ruth - Abstract:
- Abstract : Background: The latest diagnostic technique to visualize monosodium uric acid (MSU) depositions is Dual Energy CT scan (DECT). 1 Objectives: To assess the additive value and accuracy of DECT in diagnosing gout in a prospective study in subjects with unclassified arthritis. Methods: We included 100 consecutive patients with acute unclassified mono or oligo arthritis who presented to the outpatient clinic of the Department of Rheumatology of Meander Medical Centre, Amersfoort, the Netherlands, ClinicalTrials.gov NCT03038386 . Eleven patients dropped out, see Figure. Patients underwent aspiration of the arthritic joint (see Table) and a DECT scan of hands and wrists, knees, ankles and feet bilaterally. The 2015 EULAR/ACR gout classification criteria were used to score the subjects, with and without DECT result, to determine the additive value of DECT. Sensitivity and specificity of DECT for diagnosing gout were calculated separately for at the joint and at individual persons' level, using as reference standards microscopy of synovial fluid (SF) and the gout classification criteria. Results: For demographic and clinical characteristics of the patients see Table 1, and for study data and outcomes see Figure and Table 2. Sixty-eight of 89 patients (76.4%) fulfilled the 2015 EULAR/ACR criteria for gout. Of the 98 patients with SF aspiration, 55 (56%) were positive for MSU; of these, 89 subjects underwent DECT, of whom 38 had a negative microscopy result. Of these 38Abstract : Background: The latest diagnostic technique to visualize monosodium uric acid (MSU) depositions is Dual Energy CT scan (DECT). 1 Objectives: To assess the additive value and accuracy of DECT in diagnosing gout in a prospective study in subjects with unclassified arthritis. Methods: We included 100 consecutive patients with acute unclassified mono or oligo arthritis who presented to the outpatient clinic of the Department of Rheumatology of Meander Medical Centre, Amersfoort, the Netherlands, ClinicalTrials.gov NCT03038386 . Eleven patients dropped out, see Figure. Patients underwent aspiration of the arthritic joint (see Table) and a DECT scan of hands and wrists, knees, ankles and feet bilaterally. The 2015 EULAR/ACR gout classification criteria were used to score the subjects, with and without DECT result, to determine the additive value of DECT. Sensitivity and specificity of DECT for diagnosing gout were calculated separately for at the joint and at individual persons' level, using as reference standards microscopy of synovial fluid (SF) and the gout classification criteria. Results: For demographic and clinical characteristics of the patients see Table 1, and for study data and outcomes see Figure and Table 2. Sixty-eight of 89 patients (76.4%) fulfilled the 2015 EULAR/ACR criteria for gout. Of the 98 patients with SF aspiration, 55 (56%) were positive for MSU; of these, 89 subjects underwent DECT, of whom 38 had a negative microscopy result. Of these 38 subjects, 14 (37%) met the gout classification criteria only after a positive DECT result. Conclusion: Our findings suggested that DECT could have an additive value to clinical algorithms in subjects with undifferentiated arthritis when microscopy of SF fails to demonstrate the presence of MSU crystals. References: [1] Choi HK, et al. Dual energy CT in gout: a prospectieve validation study. Ann Rheum Dis2012; 71:1466-71. Disclosure of Interests: Mihaela Gamala: None declared, Johannes W. G. Jacobs Grant/research support from: Roche, Consultant for: Roche, Suzanne Linn-Rasker: None declared, Maarten Nix: None declared, Ben Heggelman: None declared, Pieternel Pasker: None declared, Jacob M. van Laar Grant/research support from: Genentech, Consultant for: F. Hoffmann-La Roche, Ruth Klaasen: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 78(2019)Supplement 2
- Issue Display:
- Volume 78, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 78
- Issue:
- 2
- Issue Sort Value:
- 2019-0078-0002-0000
- Page Start:
- 96
- Page End:
- 97
- Publication Date:
- 2019-06
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2019-eular.509 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19928.xml